Regulations.gov document
ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed…
Other · FDA-2017-D-5767 · posted Oct 3, 2017
Key facts
| Document ID | FDA-2017-D-5767-0002 |
|---|---|
| Title | ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin Guidance for Industry DRAFT GUIDANCE |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2017-D-5767 |
| Posted | Oct 3, 2017 |
| Comment period opens | Oct 3, 2017 |
| Comments due | Dec 5, 2017 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: